Dronedarone and Encorafenib: Interaction Details

Brand names
Dronedarone
Multaq
Encorafenib
Braftovi
Dr. Brian Staiger, PharmD, BCPS

Medically reviewed by ⁠

Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
Share

Share this interaction

What Happens When You Take Dronedarone With Encorafenib

What can happen when they are taken together (rated Contraindicated)

An increased risk of , increased encorafenib exposure, an increased risk of encorafenib-related adverse reactions, reduced dronedarone exposure and reduced of dronedarone

Interaction Deep Dive

A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →

Because of the possible risk of -type ventricular , giving two QT-prolonging drugs together, such as encorafenib and dronedarone, is .1 Taking them together may raise encorafenib exposure and so increase the risk of adverse reactions related to encorafenib, and it may also lower dronedarone exposure, which would diminish dronedarone efficacy.

One drug interaction study gave a single 50 mg dose of encorafenib (0.1 times the usual dose) with dilTIAZem, a moderate , and found that the encorafenib doubled (2-fold) while rose by 45%. A separate drug interaction study gave repeated doses of encorafenib 450 mg once daily plus binimetinib 45 mg twice daily together with a single 2 mg dose of midazolam, a sensitive CYP3A4 . Compared with midazolam 2 mg given alone, midazolam AUC fell by 82% and Cmax by 74%.2

The Dronedarone and Encorafenib Interaction, Explained

These two medicines should not be taken together. Both can affect the heart's electrical rhythm (called ), and using them together raises the chance of a dangerous, fast irregular heartbeat. Dronedarone (Multaq) is a heart rhythm medicine, and encorafenib (Braftovi) is a cancer medicine.

They may also change each other's levels. Dronedarone can raise encorafenib levels, which may mean more side effects. Encorafenib may lower dronedarone levels, so it may not work as well. This is based mostly on lab and drug-handling data rather than reports of harm in patients. Please don't change anything on your own. Talk with your pharmacist or doctor, who can review safer options for you.

(theoretical evidence). Mechanisms are (risk of ) and bidirectional effects.

  • Encorafenib exposure may increase: dronedarone is a moderate CYP3A4 . Reference: diltiazem (moderate CYP3A4 inhibitor) increased encorafenib 2-fold and by 45% after a single 50 mg dose.
  • Dronedarone exposure may decrease: encorafenib induces CYP3A4 (midazolam AUC fell 82% with encorafenib plus binimetinib), so dronedarone may be reduced.
  • Onset: unspecified.
  • Management: avoid . Consider an alternative antiarrhythmic or oncology regimen, with and electrolyte monitoring as clinically indicated.

See the 2 references behind this explanation ↓

From the HelloPharmacist Pharmacy Team

AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .

How we build these pages · How we use AI · Our editorial policy

Why Dronedarone and Encorafenib Interact

The likely mechanism

; of -mediated of encorafenib; of CYP3A4-mediated metabolism of dronedarone

How Drug Interactions Work Six short figures, about a minute: how one drug can raise or lower another’s level, or add to or cancel its effect. See how it works 

How to Manage the Dronedarone and Encorafenib Interaction

The documented management is to avoid combining these two medicines, so the care team will usually look for a different option rather than adjust doses.

  • Keep taking your medicines exactly as prescribed until your doctor or pharmacist tells you otherwise. Do not stop either one on your own.
  • Make sure both your heart doctor and your cancer team know you take both drugs.
  • Your team may choose an alternative treatment and may monitor your heart rhythm more closely.
  • Seek urgent help for fainting, a racing or pounding heartbeat, or severe dizziness.

Management is individual — confirm any change with your pharmacist or prescriber.

Questions for Your Pharmacist

  • Does my dose of Dronedarone or Encorafenib need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there another option that avoids this interaction?

Literature Reports

2 reports from the published literature. Each one is headed by the title of the published study it comes from.

What these reports are. Short summaries of published evidence on this combination: clinical studies, case reports and, at times, the FDA prescribing information for one of the drugs. They support this interaction, but it does not rest on them alone. It can also rest on prescribing information not summarized here, or on what is expected from how these two drugs, and others in their drug classes, are known to work.

  1. Report 1 · Study title

    Prescribing information: BRAFTOVI oral capsules, encorafenib oral capsules

    A drug interaction study found that giving dilTIAZem (a moderate ) together with a single 50 mg dose of encorafenib (0.1 times the usual dose) raised the encorafenib 2-fold and its by 45%.2

  2. Report 2 · Study title

    Prescribing information: BRAFTOVI oral capsules, encorafenib oral capsules

    In a drug interaction study, repeated dosing of encorafenib 450 mg once daily plus binimetinib 45 mg twice daily, followed by a single 2 mg dose of midazolam (a sensitive ), lowered the midazolam by 82% and the by 74% compared with midazolam 2 mg given alone.2

Dronedarone and Encorafenib: Common Questions

How serious is the Dronedarone and Encorafenib interaction?

It is rated . These should generally not be used together.

How is the Dronedarone and Encorafenib interaction managed?

The documented management is to avoid combining these two medicines, so the care team will usually look for a different option rather than adjust doses. Keep taking your medicines exactly as prescribed until your doctor or pharmacist tells you otherwise. Do not stop either one on your own. Make sure both your heart doctor and your cancer team know you take both drugs. Your team may choose an alter… Management is individual — always follow your own care team's guidance.

How quickly could this interaction happen?

The documented onset is "unspecified". The timing of this interaction is not well characterized.

How strong is the evidence for this interaction?

The evidence is graded "theoretical". Expected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.

Ask About the Dronedarone and Encorafenib Interaction

Ask in your own words about taking Dronedarone and Encorafenib together. The answer comes from this page’s interaction record and both drugs’ own information.

This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.

Try:

AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.

References (2)

  1. Product Information: MULTAQ(R) oral tablets, dronedarone oral tablets. sanofi-aventis US LLC (per manufacturer), Bridgewater, NJ, 2017. DailyMed
  2. Product Information: BRAFTOVI(R) oral capsules, encorafenib oral capsules. Array BioPharma Inc (per FDA), Boulder, CO, 2024. DailyMed
Was this write-up helpful?

Other Serious Interactions of Dronedarone and Encorafenib

Also serious with Dronedarone

Also serious with Encorafenib

These Medications Also Interact With Supplements

Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:

With Dronedarone

With Encorafenib

Check everything you take with our drug–supplement interaction checker.

Still Have Questions About This Combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

About This Library

Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →

What Each Rating Means

Severity Levels

  • Contraindicated These should generally not be used together. This interaction.
  • Major Potentially serious — often needs a change or close monitoring.
  • Moderate Can be significant — usually manageable with monitoring.
  • Minor Usually limited clinical impact.

Evidence Grades

  • EstablishedWell documented — supported by controlled studies or strong clinical data.
  • ProbableGood supporting evidence, though not definitively proven.
  • SuspectedSome evidence suggests this interaction, but it is not well established.
  • PossibleLimited or conflicting evidence; the interaction may occur.
  • TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study. This interaction.

How Soon It Shows

  • RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
  • DelayedEffects tend to build up gradually over days to weeks.
  • UnspecifiedThe timing of this interaction is not well characterized. This interaction.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Back to the answer
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.